BibTeX
CSL-JSON
MLA
Harvard
Virtual screening assisted identification of small molecule against 2019 novel coronavirus protease enzyme
release_exzdizze7vdzlbjefiocsbn22i
by
Arkadeep Sarkar,
Deepak Shilkar,
Arindam Maity,
Sarmi Sardar,
Sudhan Debnath,
Debanjan Sen,
Venkatesan Jayaprakash
Abstract
The 2019 novel coronavirus infection or COVID-19 can be designated as a global threat. Till date, there is a lack of dedicated therapeutics available against this fatal infection. In the present work, we performed structure-based drug design studies in order to identify clinically used molecules exhibiting crucial binding with 2019-coronavirus main protease enzyme. Based on ligand binding energy and interaction with essential amino acids, two molecules were selected. The stability of the complexed molecules with main protease enzyme was further studied by performing molecular dynamics simulation.
In application/xml+jats format
Archived Files and Locations
application/pdf
1.3 MB
file_qswcluxdl5fyvj3prsldgj3ova
|
vensel.org (publisher) web.archive.org (webarchive) |
Read Archived PDF
Preserved and Accessible
Type
Stage
Date 2020-05-06
article-journalStage
published
Date 2020-05-06
Work Entity
access all versions, variants, and formats of this works (eg, pre-prints)
access all versions, variants, and formats of this works (eg, pre-prints)
Cite This
Lookup Links
oaDOI/unpaywall (OA fulltext)
Crossref Metadata (via API)
Worldcat
SHERPA/RoMEO (journal policies)
wikidata.org
CORE.ac.uk
Semantic Scholar
Google Scholar
Crossref Metadata (via API)
Worldcat
SHERPA/RoMEO (journal policies)
wikidata.org
CORE.ac.uk
Semantic Scholar
Google Scholar